The research report, Global Type 2 Diabetes Epidemiology and Patient Flow Analysis - 2021, provides Type 2 Diabetes epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.
The research provides population data to characterize Type 2 Diabetes patients, history of the disease at the population level (Type 2 Diabetes prevalence, Type 2 Diabetes incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.
Research scope:
The data from this research will help executives:
The research provides population data to characterize Type 2 Diabetes patients, history of the disease at the population level (Type 2 Diabetes prevalence, Type 2 Diabetes incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.
Research scope:
- Type 2 Diabetes patient flow: Type 2 Diabetes prevalence, diagnosed, and drug-treated patients
- Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries
- Demographics: Type 2 Diabetes patients by age group, gender
- Forecast: Type 2 Diabetes epidemiology forecast to 2035
The data from this research will help executives:
- Establish basis for Type 2 Diabetes market sizing, assessing market potential, and developing drug forecast models
- Identify Type 2 Diabetes patients segments through age groups, gender, and disease sub-types
- Develop Type 2 Diabetes population-based health management frameworks
- Evaluate Type 2 Diabetes market opportunities, identify target patient population
- Align marketing decisions with the Type 2 Diabetes target population
- Communicate leadership and health authorities about your Type 2 Diabetes target patient population
Table of Contents
1. Research Methodology2. Type 2 Diabetes Patients Definition
3. US Type 2 Diabetes Epidemiology and Patient Flow
4. Germany Type 2 Diabetes Epidemiology and Patient Flow
5. France Type 2 Diabetes Epidemiology and Patient Flow
6. Italy Type 2 Diabetes Epidemiology and Patient Flow
7. Spain Type 2 Diabetes Epidemiology and Patient Flow
8. UK Type 2 Diabetes Epidemiology and Patient Flow
9. Europe Type 2 Diabetes Epidemiology and Patient Flow
10. Japan Type 2 Diabetes Epidemiology and Patient Flow
11. Global Type 2 Diabetes Epidemiology and Patient Flow
12. Sources
List of Tables
1. US Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
2. US Type 2 Diabetes Patient Sub-groups, 2020 - 2035
3. US Type 2 Diabetes Patient Flow, 2020 - 2035
4. Germany Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
5. Germany Type 2 Diabetes Patient Sub-groups, 2020 - 2035
6. Germany Type 2 Diabetes Patient Flow, 2020 - 2035
7. France Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
8. France Type 2 Diabetes Patient Sub-groups, 2020 - 2035
9. France Type 2 Diabetes Patient Flow, 2020 - 2035
10. Italy Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
11. Italy Type 2 Diabetes Patient Sub-groups, 2020 - 2035
12. Italy Type 2 Diabetes Patient Flow, 2020 - 2035
13. Spain Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
14. Spain Type 2 Diabetes Patient Sub-groups, 2020 - 2035
15. Spain Type 2 Diabetes Patient Flow, 2020 - 2035
16. UK Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
17. UK Type 2 Diabetes Patient Sub-groups, 2020 - 2035
18. UK Type 2 Diabetes Patient Flow, 2020 - 2035
19. Europe Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
20. Europe Type 2 Diabetes Patient Sub-groups, 2020 - 2035
21. Europe Type 2 Diabetes Patient Flow, 2020 - 2035
22. Japan Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
23. Japan Type 2 Diabetes Patient Sub-groups, 2020 - 2035
24. Japan Type 2 Diabetes Patient Flow, 2020 - 2035
25. Global Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
26. Global Type 2 Diabetes Patient Sub-groups, 2020 - 2035
27. Global Type 2 Diabetes Patient Flow, 2020 - 2035
List of Figures
1. US Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
2. US Type 2 Diabetes Patient by Age-Gender, 2020
3. US Type 2 Diabetes Patient Flow, 2020
4. Germany Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
5. Germany Type 2 Diabetes Patient by Age-Gender, 2020
6. Germany Type 2 Diabetes Patient Flow, 2020
7. France Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
8. France Type 2 Diabetes Patient by Age-Gender, 2020
9. France Type 2 Diabetes Patient Flow, 2020
10. Italy Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
11. Italy Type 2 Diabetes Patient by Age-Gender, 2020
12. Italy Type 2 Diabetes Patient Flow, 2020
13. Spain Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
14. Spain Type 2 Diabetes Patient by Age-Gender, 2020
15. Spain Type 2 Diabetes Patient Flow, 2020
16. UK Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
17. UK Type 2 Diabetes Patient by Age-Gender, 2020
18. UK Type 2 Diabetes Patient Flow, 2020
19. Europe Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
20. Europe Type 2 Diabetes Patient by Age-Gender, 2020
21. Europe Type 2 Diabetes Patient Flow, 2020
22. Japan Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
23. Japan Type 2 Diabetes Patient by Age-Gender, 2020
24. Japan Type 2 Diabetes Patient Flow, 2020
25. Global Type 2 Diabetes Prevalence and Incidence, 2020 - 2035
26. Global Type 2 Diabetes Patient by Age-Gender, 2020
27. Global Type 2 Diabetes Patient Flow, 2020
